ACAD logo

ACADIA Pharmaceuticals Inc. (ACAD) Return On Equity

Annual ROE:

38.89%+53.62%(+364.02%)
December 31, 2024

Summary

  • As of today, ACAD annual return on equity is 38.89%, with the most recent change of +53.62% (+364.02%) on December 31, 2024.
  • During the last 3 years, ACAD annual ROE has risen by +67.64% (+235.27%).
  • ACAD annual ROE is now -46.31% below its all-time high of 72.43%, reached on December 31, 2010.

Performance

1-Year Change

+364.02%

3-Year Change

+235.27%

5-Year Change

+197.4%

15-Year Change

+157.36%

ACAD ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

89.73%
ACAD annual return on equity is higher than 89.73% of companies in Healthcare sector

Range

All-Time High

72.43%
ACAD annual return on equity is currently -46.31% below its historical high of 72.43%

3-Year Low

-45.89%
ACAD annual return on equity is currently +184.75% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ACAD previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ACAD next annual earnings announcement has not yet been scheduled

OtherACADprofitability metrics

Annual Revenue

$957.80M
ACAD annual revenue is $957.80 million

Annual Net Income

$226.45M
ACAD annual net profit is $226.45 million

Annual EPS

$1.36
ACAD annual earnings per share is $1.36

Annual ROA

23.39%
ACAD annual return on assets is 23.39%

Quarterly ROE:

32.53%-4.92%(-13.14%)
June 30, 2025

Summary

  • As of today, ACAD quarterly return on equity is 32.53%, with the most recent change of -4.92% (-13.14%) on June 30, 2025.
  • Over the past year, ACAD quarterly ROE has increased by +25.49% (+362.07%).
  • ACAD quarterly ROE is now -77.70% below its all-time high of 145.90%, reached on December 31, 2010.

Performance

3-Month Change

-13.14%

1-Year Change

+362.07%

3-Year Change

+181.16%

5-Year Change

+188.95%

ACAD Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

88.14%
ACAD quarterly return on equity is higher than 88.14% of companies in Healthcare sector

Range

All-Time High

145.90%
ACAD quarterly return on equity is currently -77.70% below its historical high of 145.90%

3-Year Low

-48.07%
ACAD quarterly return on equity is currently +167.67% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
ACAD previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 5, 2025
ACAD next earnings announcement is scheduled for Nov 5, 2025

OtherACADprofitability metrics

Quarterly Revenue

$264.57M
ACAD quarterly revenue is $264.57 million

Quarterly Net Income

$26.67M
ACAD quarterly net profit is $26.67 million

Quarterly EPS

$0.16
ACAD quarterly earnings per share is $0.16

Quarterly ROA

20.43%
ACAD quarterly return on assets is 20.43%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

38.89%
ACAD annual return on equity is 38.89%

Annual Net Income

$226.45M
ACAD annual net profit is $226.45 million

Annual Shareholders Equity

$732.79M
ACAD annual stockholders equity is $732.79 million

ACAD ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+364.0%+362.1%
3Y3 Years+235.3%+181.2%
5Y5 Years+197.4%+188.9%

ACAD ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+184.8%-21.8%+167.7%
5Y5-Yearat high+184.8%-21.8%+167.7%
All-TimeAll-Time-46.3%+128.0%-77.7%+111.8%

ACAD ROE History

DateAnnualQuarterly
Jun 2025
-
32.53%(-13.1%)
Mar 2025
-
37.45%(-10.0%)
Dec 2024
38.89%(+364.0%)
41.59%(+52.2%)
Sep 2024
-
27.32%(+288.1%)
Jun 2024
-
7.04%(+1776.2%)
Mar 2024
-
-0.42%(+97.3%)
Dec 2023
-14.73%(+67.9%)
-15.60%(+58.9%)
Sep 2023
-
-37.99%(-39.3%)
Jun 2023
-
-27.28%(+22.2%)
Mar 2023
-
-35.08%(+27.0%)
Dec 2022
-45.89%(-59.6%)
-48.07%(-6.8%)
Sep 2022
-
-45.03%(-12.4%)
Jun 2022
-
-40.08%(-0.9%)
Mar 2022
-
-39.73%(-36.4%)
Dec 2021
-28.75%(+32.3%)
-29.13%(+8.9%)
Sep 2021
-
-31.97%(+24.5%)
Jun 2021
-
-42.33%(-3.0%)
Mar 2021
-
-41.08%(+4.2%)
Dec 2020
-42.47%(-6.4%)
-42.89%(-7.1%)
Sep 2020
-
-40.04%(-9.5%)
Jun 2020
-
-36.57%(+12.9%)
Mar 2020
-
-41.99%(+4.5%)
Dec 2019
-39.93%(+33.7%)
-43.98%(+21.9%)
Sep 2019
-
-56.32%(+25.4%)
Jun 2019
-
-75.48%(+7.6%)
Mar 2019
-
-81.73%(-7.1%)
Dec 2018
-60.22%(+11.2%)
-76.30%(+7.6%)
Sep 2018
-
-82.59%(-11.4%)
Jun 2018
-
-74.17%(-9.5%)
Mar 2018
-
-67.71%(+1.6%)
Dec 2017
-67.80%(+10.3%)
-68.78%(-7.9%)
Sep 2017
-
-63.76%(+0.8%)
Jun 2017
-
-64.26%(0.0%)
Mar 2017
-
-64.26%(-1.8%)
Dec 2016
-75.58%(-17.0%)
-63.11%(+1.6%)
Sep 2016
-
-64.13%(+4.2%)
Jun 2016
-
-66.94%(-8.8%)
Mar 2016
-
-61.50%(+4.4%)
Dec 2015
-64.58%(-71.7%)
-64.36%(-23.3%)
Sep 2015
-
-52.20%(-20.3%)
Jun 2015
-
-43.40%(-23.8%)
Mar 2015
-
-35.05%(-16.6%)
Dec 2014
-37.62%
-30.07%(-11.2%)
Sep 2014
-
-27.03%(-9.7%)
Jun 2014
-
-24.63%(+0.1%)
DateAnnualQuarterly
Mar 2014
-
-24.65%(+3.3%)
Dec 2013
-26.65%(+19.5%)
-25.49%(+9.6%)
Sep 2013
-
-28.20%(+4.9%)
Jun 2013
-
-29.64%(+29.2%)
Mar 2013
-
-41.86%(+30.1%)
Dec 2012
-33.09%(+61.4%)
-59.92%(+38.4%)
Sep 2012
-
-97.22%(-1.2%)
Jun 2012
-
-96.03%(-16.2%)
Mar 2012
-
-82.67%(-10.5%)
Dec 2011
-85.82%(-218.5%)
-74.82%(-264.8%)
Sep 2011
-
45.40%(-24.9%)
Jun 2011
-
60.45%(-36.4%)
Mar 2011
-
94.98%(-34.9%)
Dec 2010
72.43%(+152.2%)
145.90%(+152.9%)
Sep 2010
-
-275.64%(-37.4%)
Jun 2010
-
-200.68%(-16.0%)
Mar 2010
-
-173.01%(-14.1%)
Dec 2009
-138.68%(-80.2%)
-151.63%(-22.1%)
Sep 2009
-
-124.19%(-15.0%)
Jun 2009
-
-108.03%(-16.0%)
Mar 2009
-
-93.14%(-19.8%)
Dec 2008
-76.97%(-23.6%)
-77.77%(-13.2%)
Sep 2008
-
-68.72%(-15.2%)
Jun 2008
-
-59.66%(-7.7%)
Mar 2008
-
-55.41%(-0.6%)
Dec 2007
-62.28%(+26.4%)
-55.08%(-1.3%)
Sep 2007
-
-54.37%(-0.6%)
Jun 2007
-
-54.03%(+25.7%)
Mar 2007
-
-72.76%(-1.1%)
Dec 2006
-84.67%(+13.1%)
-71.97%(+0.8%)
Sep 2006
-
-72.54%(+8.1%)
Jun 2006
-
-78.91%(+8.0%)
Mar 2006
-
-85.75%(-6.9%)
Dec 2005
-97.46%(-122.3%)
-80.22%(-8.1%)
Sep 2005
-
-74.18%(-20.4%)
Jun 2005
-
-61.60%(+10.5%)
Mar 2005
-
-68.79%(-27.0%)
Dec 2004
-43.85%(-562.4%)
-54.18%(+40.1%)
Sep 2004
-
-90.47%(+54.0%)
Jun 2004
-
-196.59%(-2239.2%)
Mar 2004
-
9.19%(+279.8%)
Dec 2003
-6.62%(+86.9%)
2.42%
Dec 2002
-50.63%(-501.2%)
-
Dec 2001
12.62%(+248.5%)
-
Dec 2000
-8.50%
-

FAQ

  • What is ACADIA Pharmaceuticals Inc. annual return on equity?
  • What is the all-time high annual ROE for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. annual ROE year-on-year change?
  • What is ACADIA Pharmaceuticals Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. quarterly ROE year-on-year change?

What is ACADIA Pharmaceuticals Inc. annual return on equity?

The current annual ROE of ACAD is 38.89%

What is the all-time high annual ROE for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high annual return on equity is 72.43%

What is ACADIA Pharmaceuticals Inc. annual ROE year-on-year change?

Over the past year, ACAD annual return on equity has changed by +53.62% (+364.02%)

What is ACADIA Pharmaceuticals Inc. quarterly return on equity?

The current quarterly ROE of ACAD is 32.53%

What is the all-time high quarterly ROE for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high quarterly return on equity is 145.90%

What is ACADIA Pharmaceuticals Inc. quarterly ROE year-on-year change?

Over the past year, ACAD quarterly return on equity has changed by +25.49% (+362.07%)
On this page